Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Epoch Biosciences was a biotechnology company that developed and commercialized proprietary genetic analysis tools and reagents. The company's core innovation was the Minor Groove Binder (MGB) technology, which significantly improved the performance of DNA probes by increasing their melting temperature and specificity. This technology enabled the creation of shorter, more robust probes for real-time PCR and other molecular diagnostic applications. Epoch's product line included the MGB Eclipse Probe System and a variety of specialized fluorescent dyes such as Yakima Yellow and Redmond Red. The company operated primarily through a licensing model, partnering with major life science entities like Applied Biosystems to integrate its technologies into widely used diagnostic kits. Epoch Biosciences was acquired by Nanogen in 2004, and its intellectual property remains a foundational component of modern molecular diagnostics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Epoch Biosciences.